Healthcare Simulation Market Share Report | Size and Forecasts (2023-2030)

Coverage: Healthcare Simulation Market covers analysis By Product and Services {Medical Anatomical Models (Patient Simulators, Task Trainers, Interventional/Surgical Simulators, Endovascular Simulators, Ultrasound Simulators, Dental Simulators, Eye Simulators), Web-based Simulators, Healthcare Simulation Software, and Simulation Training Services}, Technology (3D Printing, Virtual Patient Simulation, and Procedure Rehearsal Technology), End-user (Hospitals, Academic Institutes, Military Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

  • Report Code : TIPRE00022285
  • Category : Healthcare IT
  • No. of Pages : 150
Buy Now

Healthcare Simulation Market Insights and Growth by 2031

Buy Now

[Research Report] The Healthcare Simulation market size is projected to grow from US$ 2,130.14 million in 2022 to US$ 7234.19 million by 2031; it is estimated to record a CAGR of 16.5% during 2022–2031.

Market Insights and Analyst View:

Healthcare Simulation is the modern way to train and educate healthcare professionals to master technical, cognitive, and behavioral skill sets through technologically advanced and crafted experiences. This experiential learning style helps learners and professionals test and practice their profession while boosting confidence in their capabilities before working in real-world scenarios. Additionally, medical simulation mimics a clinical situation without the risk of potentially dangerous clinical outcomes. Healthcare simulation is also called clinical simulation, medical simulation, or, in specific circumstances, nursing simulation and surgical simulation.     

Factors that positively affect the Healthcare Simulation market are the growing demand for minimally invasive procedures across the globe, which boosts the need for healthcare simulation. Also, the rising technological advancements and the increasing focus on patient safety drive investment in the Healthcare Simulation market.

Growth Drivers:

Medical simulation technology has come a long way in recent years, with advancements in virtual reality, machine learning, and haptics leading to more effective and realistic simulations for healthcare education. One prominent advancement in medical simulation technology is virtual reality (VR) technology. Using VR, users can interact with medical equipment and virtual patients in a realistic environment, enabling them to practice procedures and develop clinical skills without harming real patients. Another advancement in medical simulation technology is haptic technology, which enables users to feel realistic sensations such as temperature, pressure, and texture. It allows students to experience the tactile sensations of performing surgeries and procedures, making the simulations more effective and realistic. Machine learning is also being used to enhance the effectiveness and realism of medical simulations. Machine learning algorithms can use data from real patients to create realistic virtual patients with symptoms and complex conditions, enabling students to practice diagnosing and treating these diseases in a realistic environment. With the growing use of artificial intelligence, simulation models are becoming more sophisticated, accurate, and realistic, helping to improve the training of healthcare professionals. In recent years, medical simulation technology has advanced significantly with haptics, machine learning, virtual reality, and artificial intelligence, leading to more effective and realistic simulations for healthcare education. These state-of-the-art simulation technologies provide students with an immersive and safe learning experience, enabling them to develop their clinical skills and enhance patient outcomes. Therefore, the technological advancements, driving the Healthcare Simulation market.  

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Healthcare Simulation Market: Strategic Insights

healthcare-simulation-market
Market Size Value inUS$ 2,130.14 million in 2022
Market Size Value byUS$ 7234.19 million by 2030
Growth rateCAGR of 16.5% from 2022 to 2030
Forecast Period2022-2030
Base Year2022
Analyst Image

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Report Segmentation and Scope:

The “Healthcare Simulation Market” is segmented based on product and services, technology, end user, and geography. Based on products and services, the market is segmented into medical anatomical models, web-based simulators, healthcare simulation software, and simulation training services. The Medical Anatomical Models segment is further sub-segmented as patient simulators, task trainers, interventional/surgical simulators, ultrasound, endovascular, dental, and eye simulators. In terms of technology, the Healthcare Simulation market is segmented into 3D printing, virtual patient simulation, and procedure rehearsal technology. Based on the end user, the market is categorized into hospitals, academic institutes, military organizations, and others.   The Healthcare Simulation market, based on geography is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Segmental Analysis:

Based on products and services, the market is segmented into medical anatomical models, web-based simulators, healthcare simulation software, and simulation training services. The Medical Anatomical Models segment is further sub-segmented as patient simulators, task trainers, interventional/surgical simulators, endovascular simulators, ultrasound simulators, dental simulators, and eye simulators. The medical anatomical models segment held the largest share of the market in 2022 and web-based simulators are estimated to register the highest CAGR in the market during 2022-2031. The benefits of training fine motor skills using a variety of simulated procedures are undebatable. The anatomical model is an essential component that highly contributes to successful simulation. Physical anatomy is as vital as virtual anatomy in medical simulation training.

Additionally, due to the simulated part of the surgery, educational value can be increased if what is on the outside feels and looks equally realistic. A physically accurate anatomical model a trainee can manipulate is an inseparable part of successful training in multiple medical specialties. Fully articulated anatomical models are available with highly realistic simulation scenarios, an important requirement for successful and patient safety-focused training. With new product launches and the increase in minimally invasive surgeries, the medical anatomical models segment is expected to hold a significant share of the Healthcare Simulation market.   

In terms of technology, the Healthcare Simulation market is segmented into 3D printing, virtual patient simulation, and procedure rehearsal technology. The procedure rehearsal technology segment held the largest market share in 2022, and virtual patient simulation is anticipated to grow fastest from 2022 to 2031.  Medical simulation is generally used to assist a resident or fellow in performing a procedure to enhance proficiency. In recent years, the term ‘rehearsal’ has started to appear in the medical literature as a way medical simulation can enhance clinical performance. Simulation is becoming extensively used in medical training to allow physicians to acquire, enhance, and sustain complex procedural skills. The Simbionix PROcedure Rehearsal Studio, a technology-evolved new product, allows a technician or clinician to take computed tomography angiography (CTA) scan data of a patient, and import it into the Simbionix ANGIO Mentor, which is an endovascular simulation. If properly used, this new technology could enlarge the role of medical simulation in enhancing patient care. With the advantages of procedure rehearsal technology and the increase in minimally invasive surgeries, the procedure rehearsal technology segment is expected to hold a significant share of the Healthcare Simulation market.  

Based on the end user, the market is categorized into hospitals, academic institutes, military organizations, and others. The hospitals segment held the largest market share in 2022. However, the academic institutes segment is anticipated to register the highest CAGR during 2022-2031.  Healthcare costs continue to increase as raised demand for services and limited budgets pressurize resources; however, they may be used efficiently. Proposes discrete event simulation as an efficient tool in the search for highly efficient health care systems—the application of a desktop computer simulation package to model part of a hospital subsystem. The simulation package shows how effectively it might be enhanced by moderating available resources and time to finish tasks. Maintains that the principles expounded and apply to many aspects of health care management. Hospitals rapidly adopting simulation technologies for better management and increased patient safety. Thus, the abovementioned factors are likely to drive the growth of the hospital segment during the forecast period.  

Regional Analysis:

Based on geography, the Healthcare Simulation market is divided into five key regions: North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa. North America will likely capture a significant global Healthcare Simulation market share in 2022. The market growth in the region is attributed to the growing demand for minimally invasive procedures, Rising technological advancements, and Increasing focus on patient safety. In addition, a growing number of market players are expanding their geographical footprint in North American countries.        

Minimally invasive surgeries grow with a higher acceptance rate over traditional surgeries due to the increasing prevalence of lifestyle-related and chronic disorders and technological advancements. The US shows a growing prevalence of chronic diseases, which is expected to create more demand for minimally invasive surgeries for disease management. The rising prevalence of chronic diseases is likely to boost market growth. Chronic diseases such as cancer, stroke, neurological disorders, and paralysis are the top causes of death and disability in the US. According to the National Center for Chronic Disease Prevention and Health Promotion, 6 in 10 Americans have at least one chronic disease, such as stroke, cancer, neurological disorders, and others. For instance, According to the Centers for Disease Control and Prevention (CDC), in 2021, ~695,000 people died from heart disease in the US, with coronary heart disease being the most common type of heart disease that resulted in the death of 375,476 people in the country. According to the Diabetes Research Institute, the number of people with diabetes in the US was ~37.3 million (11.3% of the population) in 2022. Nearly 28.7 million people in the US were diagnosed with diabetes, and approximately 8.6 million people have undiagnosed diabetes.       

Further, ~1.4 million diabetes cases are diagnosed each year in the US. According to the Centers for Disease Control and Prevention, in 2021, ~88 million adults had prediabetes, which is 34.5% of the US adult population. According to the Canadian Diabetes Association, in 2022, there is an increasing prevalence of diabetes in the country, with 11.7 million reported cases of diabetes or prediabetes. According to the same source, ~5.7 million Canadians are living with diagnosed diabetes. According to Statistics Canada, Canada has a low fertility rate, decreasing from 1.47 children per woman in 2021 to 1.40 children per woman in 2021.  According to the Canadian Institute for Health Information, in July 2022, ~2.4 million people were diagnosed with heart disease. It was the second major cause of death after cancer in Canada. Demand for minimally invasive procedures has increased remarkably over the past few years to reduce the burden associated with a wide range of chronic diseases.    

Industry Developments and Future Opportunities:

Various initiatives taken by key players operating in the global Healthcare Simulation market are listed below:

  1. In January 2023, The U.S. Agency for International Development (USAID) launched a new Advanced Simulation Laboratory Center at the Christian Medical College (CMC) in Vellore for the training of their nurses, emergency teams, and doctors in neonatal care and maternal, including in the latest technologies to respond to basic and advanced nursing procedures, cardiopulmonary resuscitation (CPR), and mother and infant emergencies.  
  2. In September 2021, Nasco Healthcare launched its strategic partnership agreement with SKILLQUBE GmbH worldwide to obtain the most realistic patient monitoring and medical device emulation solutions available to the marketplace.
  3. In July 2021, 3D Systems signed a definitive agreement to sell Simbionix, its medical simulation business, to Surgical Science Sweden AB for a $305 million purchase price, subject to customary closing conditions and adjustments.
  4. In October 2023, 3B Scientific, a leading manufacturer and marketer of medical simulation products and anatomical models for healthcare education, acquired Wallcur LLC, a prominent provider of healthcare simulation products. This acquisition broadens 3B Scientific's product offering and demonstrates its ongoing commitment to advancing medical training.
  5. In October 2023, Paul Hastings LLP, advising Madison Industries, one of the world’s largest privately held companies, acquired CAE Healthcare. This technology company makes the globe safer through cutting-edge medical simulation and training solutions.    
  6. In October 2023, Lumeto, the Toronto-based XR healthcare simulation company, announced a landmark AI upgrade to its InvolveXR platform. InvolveXR is a fully immersive and highly flexible XR Simulation Lab for institutions looking to deploy immersive training and assessment across the healthcare spectrum. The platform is now equipped with a Large Language Model (LLM) based AI-driven customizable conversational system, allowing unprecedented adaptability for simulating virtual patient encounters.

Competitive Landscape and Key Companies:

CAE (Canadian Aviation Electronics, Ltd), Laerdal Medical, 3D Systems, Simulab Corporation, Limbs & Things Ltd, Simulaids, Kyoto Kagaku Co., Ltd, Gaumard Scientific Company, Mentice AB, Surgical Science Sweden AB, VirtaMed AG, Operative Experience, Inc. are the major Healthcare Simulation companies. These companies focus on new technologies, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide. 

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product and Services, Technology, End-user, and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Healthcare Simulation Market - By Products and Services
1.3.2 Healthcare Simulation Market - By End User
1.3.3 Healthcare Simulation Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HEALTHCARE SIMULATION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HEALTHCARE SIMULATION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HEALTHCARE SIMULATION MARKET - GLOBAL MARKET ANALYSIS
6.1. HEALTHCARE SIMULATION - GLOBAL MARKET OVERVIEW
6.2. HEALTHCARE SIMULATION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. HEALTHCARE SIMULATION MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCTS AND SERVICES
7.1. OVERVIEW
7.2. PRODUCTS AND SERVICES MARKET FORECASTS AND ANALYSIS
7.3. HEALTHCARE ANATOMICAL MODELS
7.3.1. Overview
7.3.2. Healthcare Anatomical Models Market Forecast and Analysis
7.3.3. Patient Simulators Market
7.3.3.1. Overview
7.3.3.2. Patient Simulators Market Forecast and Analysis
7.3.4. Task Trainers Market
7.3.4.1. Overview
7.3.4.2. Task Trainers Market Forecast and Analysis
7.3.5. Surgical Simulators Market
7.3.5.1. Overview
7.3.5.2. Surgical Simulators Market Forecast and Analysis
7.3.6. Endovascular Simulators Market
7.3.6.1. Overview
7.3.6.2. Endovascular Simulators Market Forecast and Analysis
7.3.7. Ultrasound Simulators Market
7.3.7.1. Overview
7.3.7.2. Ultrasound Simulators Market Forecast and Analysis
7.3.8. Dental Simulators Market
7.3.8.1. Overview
7.3.8.2. Dental Simulators Market Forecast and Analysis
7.3.9. Eye Simulators Market
7.3.9.1. Overview
7.3.9.2. Eye Simulators Market Forecast and Analysis
7.4. WEB BASED SIMULATORS
7.4.1. Overview
7.4.2. Web Based Simulators Market Forecast and Analysis
7.5. HEALTHCARE SIMULATION SOFTWARE
7.5.1. Overview
7.5.2. Healthcare Simulation Software Market Forecast and Analysis
7.6. SIMULATION TRAINING SERVICES
7.6.1. Overview
7.6.2. Simulation Training Services Market Forecast and Analysis
8. HEALTHCARE SIMULATION MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. ACADEMIC INSTITUTES
8.3.1. Overview
8.3.2. Academic Institutes Market Forecast and Analysis
8.4. HOSPITALS
8.4.1. Overview
8.4.2. Hospitals Market Forecast and Analysis
8.5. MILITARY ORGANIZATION
8.5.1. Overview
8.5.2. Military Organization Market Forecast and Analysis
8.6. RESEARCH
8.6.1. Overview
8.6.2. Research Market Forecast and Analysis
9. HEALTHCARE SIMULATION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Healthcare Simulation Market Overview
9.1.2 North America Healthcare Simulation Market Forecasts and Analysis
9.1.3 North America Healthcare Simulation Market Forecasts and Analysis - By Products and Services
9.1.4 North America Healthcare Simulation Market Forecasts and Analysis - By End User
9.1.5 North America Healthcare Simulation Market Forecasts and Analysis - By Countries
9.1.5.1 United States Healthcare Simulation Market
9.1.5.1.1 United States Healthcare Simulation Market by Products and Services
9.1.5.1.2 United States Healthcare Simulation Market by End User
9.1.5.2 Canada Healthcare Simulation Market
9.1.5.2.1 Canada Healthcare Simulation Market by Products and Services
9.1.5.2.2 Canada Healthcare Simulation Market by End User
9.1.5.3 Mexico Healthcare Simulation Market
9.1.5.3.1 Mexico Healthcare Simulation Market by Products and Services
9.1.5.3.2 Mexico Healthcare Simulation Market by End User
9.2. EUROPE
9.2.1 Europe Healthcare Simulation Market Overview
9.2.2 Europe Healthcare Simulation Market Forecasts and Analysis
9.2.3 Europe Healthcare Simulation Market Forecasts and Analysis - By Products and Services
9.2.4 Europe Healthcare Simulation Market Forecasts and Analysis - By End User
9.2.5 Europe Healthcare Simulation Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Healthcare Simulation Market
9.2.5.1.1 Germany Healthcare Simulation Market by Products and Services
9.2.5.1.2 Germany Healthcare Simulation Market by End User
9.2.5.2 France Healthcare Simulation Market
9.2.5.2.1 France Healthcare Simulation Market by Products and Services
9.2.5.2.2 France Healthcare Simulation Market by End User
9.2.5.3 Italy Healthcare Simulation Market
9.2.5.3.1 Italy Healthcare Simulation Market by Products and Services
9.2.5.3.2 Italy Healthcare Simulation Market by End User
9.2.5.4 Spain Healthcare Simulation Market
9.2.5.4.1 Spain Healthcare Simulation Market by Products and Services
9.2.5.4.2 Spain Healthcare Simulation Market by End User
9.2.5.5 United Kingdom Healthcare Simulation Market
9.2.5.5.1 United Kingdom Healthcare Simulation Market by Products and Services
9.2.5.5.2 United Kingdom Healthcare Simulation Market by End User
9.2.5.6 Rest of Europe Healthcare Simulation Market
9.2.5.6.1 Rest of Europe Healthcare Simulation Market by Products and Services
9.2.5.6.2 Rest of Europe Healthcare Simulation Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Healthcare Simulation Market Overview
9.3.2 Asia-Pacific Healthcare Simulation Market Forecasts and Analysis
9.3.3 Asia-Pacific Healthcare Simulation Market Forecasts and Analysis - By Products and Services
9.3.4 Asia-Pacific Healthcare Simulation Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Healthcare Simulation Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Healthcare Simulation Market
9.3.5.1.1 Australia Healthcare Simulation Market by Products and Services
9.3.5.1.2 Australia Healthcare Simulation Market by End User
9.3.5.2 China Healthcare Simulation Market
9.3.5.2.1 China Healthcare Simulation Market by Products and Services
9.3.5.2.2 China Healthcare Simulation Market by End User
9.3.5.3 India Healthcare Simulation Market
9.3.5.3.1 India Healthcare Simulation Market by Products and Services
9.3.5.3.2 India Healthcare Simulation Market by End User
9.3.5.4 Japan Healthcare Simulation Market
9.3.5.4.1 Japan Healthcare Simulation Market by Products and Services
9.3.5.4.2 Japan Healthcare Simulation Market by End User
9.3.5.5 South Korea Healthcare Simulation Market
9.3.5.5.1 South Korea Healthcare Simulation Market by Products and Services
9.3.5.5.2 South Korea Healthcare Simulation Market by End User
9.3.5.6 Rest of Asia-Pacific Healthcare Simulation Market
9.3.5.6.1 Rest of Asia-Pacific Healthcare Simulation Market by Products and Services
9.3.5.6.2 Rest of Asia-Pacific Healthcare Simulation Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Healthcare Simulation Market Overview
9.4.2 Middle East and Africa Healthcare Simulation Market Forecasts and Analysis
9.4.3 Middle East and Africa Healthcare Simulation Market Forecasts and Analysis - By Products and Services
9.4.4 Middle East and Africa Healthcare Simulation Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Healthcare Simulation Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Healthcare Simulation Market
9.4.5.1.1 South Africa Healthcare Simulation Market by Products and Services
9.4.5.1.2 South Africa Healthcare Simulation Market by End User
9.4.5.2 Saudi Arabia Healthcare Simulation Market
9.4.5.2.1 Saudi Arabia Healthcare Simulation Market by Products and Services
9.4.5.2.2 Saudi Arabia Healthcare Simulation Market by End User
9.4.5.3 U.A.E Healthcare Simulation Market
9.4.5.3.1 U.A.E Healthcare Simulation Market by Products and Services
9.4.5.3.2 U.A.E Healthcare Simulation Market by End User
9.4.5.4 Rest of Middle East and Africa Healthcare Simulation Market
9.4.5.4.1 Rest of Middle East and Africa Healthcare Simulation Market by Products and Services
9.4.5.4.2 Rest of Middle East and Africa Healthcare Simulation Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Healthcare Simulation Market Overview
9.5.2 South and Central America Healthcare Simulation Market Forecasts and Analysis
9.5.3 South and Central America Healthcare Simulation Market Forecasts and Analysis - By Products and Services
9.5.4 South and Central America Healthcare Simulation Market Forecasts and Analysis - By End User
9.5.5 South and Central America Healthcare Simulation Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Healthcare Simulation Market
9.5.5.1.1 Brazil Healthcare Simulation Market by Products and Services
9.5.5.1.2 Brazil Healthcare Simulation Market by End User
9.5.5.2 Argentina Healthcare Simulation Market
9.5.5.2.1 Argentina Healthcare Simulation Market by Products and Services
9.5.5.2.2 Argentina Healthcare Simulation Market by End User
9.5.5.3 Rest of South and Central America Healthcare Simulation Market
9.5.5.3.1 Rest of South and Central America Healthcare Simulation Market by Products and Services
9.5.5.3.2 Rest of South and Central America Healthcare Simulation Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL HEALTHCARE SIMULATION MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. HEALTHCARE SIMULATION MARKET, KEY COMPANY PROFILES
12.1. CAE INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. 3D SYSTEMS
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. LAERDAL
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. GAUMARD SCIENTIFIC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. LIMBS AND THINGS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MENTICE
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. KYOTO KAGAKU CO., LTD.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. INTELLIGENT ULTRASOUND
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SIMULAB CORPORATION
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SIMULAIDS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS


* Above given report scope is tentative, and may change during the study process as per the research requirement.
* List of companies provided under ‘Company Profile’ chapter is tentative and may change during the course of the study. This list is customizable as per the client requirements.
* Financial information would be provided only for the public companies.

The List of Companies

1. CAE Inc.
2. 3D Systems
3. Laerdal
4. Gaumard Scientific
5. Limbs & Things
6. Mentice
7. Kyoto Kagaku Co., Ltd.
8. Intelligent Ultrasound
9. Simulab Corporation
10. Simulaids
11. Operative Experience, Inc.
12. Surgical Science
13. Cardionics, Inc.
14. VirtaMed
15. SYNBONE

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Healthcare IT : READ MORE..